# Predetermined Change Control Plan (PCCP) Template

**Document Version**: 1.0
**Last Updated**: [DATE]
**Device Name**: [DEVICE NAME]
**Model/Version**: [MODEL/VERSION]

---

## 1. Executive Summary

This document describes the Predetermined Change Control Plan (PCCP) for [DEVICE NAME], an AI/ML-enabled medical device. The PCCP outlines the types of modifications that may be made to the device's machine learning algorithm without requiring a new premarket submission, along with the methods and controls to ensure continued safety and effectiveness.

**Reference**: FDA Draft Guidance - Artificial Intelligence-Enabled Device Software Functions (January 2025)

---

## 2. Device Description

### 2.1 Device Overview

| Field | Description |
|-------|-------------|
| Device Name | [DEVICE NAME] |
| Intended Use | [INTENDED USE STATEMENT] |
| Indications for Use | [INDICATIONS FOR USE] |
| Target Population | [TARGET PATIENT POPULATION] |
| User Population | [HEALTHCARE PROVIDERS/USERS] |

### 2.2 AI/ML Algorithm Description

| Field | Description |
|-------|-------------|
| Algorithm Type | [e.g., Convolutional Neural Network, Random Forest] |
| Framework | [e.g., PyTorch 2.0, TensorFlow 2.15] |
| Architecture | [e.g., ResNet-50, EfficientNet-B4] |
| Input Type | [e.g., DICOM images, tabular data] |
| Output Type | [e.g., classification, probability score] |

### 2.3 Current Performance Baseline

Document the current validated performance:

| Metric | Value | 95% CI |
|--------|-------|--------|
| Sensitivity | [XX.X%] | [XX.X% - XX.X%] |
| Specificity | [XX.X%] | [XX.X% - XX.X%] |
| AUC | [X.XXX] | [X.XXX - X.XXX] |
| Accuracy | [XX.X%] | [XX.X% - XX.X%] |

---

## 3. Modification Categories

### 3.1 Category A: Training Data Updates

**Description**: Updates to training data that do not change the model architecture or intended use.

**Included Changes**:
- [ ] Addition of new training samples within the existing data distribution
- [ ] Correction of labeling errors in existing training data
- [ ] Augmentation with synthetic data generated from approved methods
- [ ] Rebalancing of class distributions

**Excluded Changes**:
- [ ] Data from new imaging modalities
- [ ] Data from patient populations not originally validated
- [ ] Data with different acquisition parameters

**Validation Requirements**:
1. New data must pass data quality checks (outlier detection, distribution analysis)
2. Model retrained on updated dataset
3. Performance evaluation on held-out test set
4. Subgroup analysis for protected attributes
5. Comparison to baseline performance

**Acceptance Criteria**:
- Sensitivity: >= [BASELINE - TOLERANCE]
- Specificity: >= [BASELINE - TOLERANCE]
- No statistically significant performance degradation in any subgroup

### 3.2 Category B: Model Retraining

**Description**: Periodic retraining of the existing model architecture with updated data.

**Included Changes**:
- [ ] Scheduled periodic retraining (e.g., quarterly)
- [ ] Retraining triggered by drift detection alerts
- [ ] Fine-tuning on new data batches

**Excluded Changes**:
- [ ] Changes to model architecture
- [ ] Changes to input preprocessing
- [ ] Changes to output interpretation

**Validation Requirements**:
1. Complete performance evaluation on validation dataset
2. Comparison to previous model version
3. Regression testing for known failure cases
4. Adversarial robustness testing
5. Bias/fairness evaluation

**Acceptance Criteria**:
- All primary metrics within [X%] of baseline
- No new failure modes introduced
- Adversarial robustness maintained
- Fairness metrics pass thresholds

### 3.3 Category C: Hyperparameter Optimization

**Description**: Adjustments to model hyperparameters within predefined ranges.

**Included Changes**:
- [ ] Learning rate: [MIN] to [MAX]
- [ ] Batch size: [MIN] to [MAX]
- [ ] Regularization strength: [MIN] to [MAX]
- [ ] Number of training epochs: [MIN] to [MAX]

**Excluded Changes**:
- [ ] Changes outside predefined ranges
- [ ] Changes to network architecture
- [ ] Changes to loss function

**Validation Requirements**:
1. Performance evaluation on validation set
2. Verification of convergence
3. Overfitting assessment

---

## 4. Modification Protocol

### 4.1 Data Management Practices

#### 4.1.1 Data Quality Requirements

- [ ] Data must pass automated quality checks
- [ ] Data poisoning defense validation required
- [ ] Demographic distribution must match target population
- [ ] Annotation must follow established guidelines

#### 4.1.2 Data Documentation

| Requirement | Description |
|-------------|-------------|
| Source | [Document data sources] |
| Collection | [Document collection methods] |
| Annotation | [Document annotation process] |
| Version Control | [Document data versioning] |

### 4.2 Retraining Practices

#### 4.2.1 Training Environment

- [ ] Use version-controlled training environment
- [ ] Document all dependencies (SBOM)
- [ ] Use deterministic training when possible
- [ ] Record all hyperparameters and random seeds

#### 4.2.2 Model Versioning

| Field | Requirement |
|-------|-------------|
| Version Format | [e.g., MAJOR.MINOR.PATCH] |
| Storage | [e.g., MLflow, DVC] |
| Integrity | SHA-256 hash of model weights |
| Lineage | Parent model version |

### 4.3 Performance Evaluation

#### 4.3.1 Test Datasets

| Dataset | Size | Purpose |
|---------|------|---------|
| Validation Set | [N samples] | Hyperparameter tuning |
| Test Set | [N samples] | Performance evaluation |
| Subgroup Sets | [N samples each] | Fairness evaluation |

#### 4.3.2 Evaluation Protocol

1. Evaluate on held-out test set (never used in training)
2. Calculate primary performance metrics with 95% CIs
3. Perform subgroup analysis by protected attributes
4. Compare to baseline and previous version
5. Document any performance changes

### 4.4 Update Procedures

#### 4.4.1 Deployment Mechanics

- [ ] Staged rollout (e.g., 5% -> 25% -> 100%)
- [ ] Rollback capability within [X hours]
- [ ] A/B testing for performance comparison
- [ ] User notification of update

#### 4.4.2 User Communication

| Event | Communication |
|-------|---------------|
| Update Available | [Notification method] |
| Update Deployed | [Notification method] |
| Rollback | [Notification method] |

#### 4.4.3 Labeling Updates

- [ ] Version number updated in software
- [ ] Performance claims updated if changed
- [ ] User manual updated if workflow affected

---

## 5. Cybersecurity Validation

### 5.1 Pre-Deployment Security Checks

- [ ] Model integrity verification (cryptographic hash)
- [ ] Adversarial robustness testing
- [ ] Data poisoning defense validation
- [ ] SBOM updated and scanned for vulnerabilities
- [ ] Security regression testing

### 5.2 Security Metrics

| Test | Threshold | Method |
|------|-----------|--------|
| FGSM Robustness | >= [X%] | [Description] |
| PGD Robustness | >= [X%] | [Description] |
| Data Poisoning | < [X%] contamination | [Description] |

---

## 6. Real-World Monitoring

### 6.1 Performance Monitoring

| Metric | Frequency | Alert Threshold |
|--------|-----------|-----------------|
| Accuracy | Daily | < [X%] |
| Drift Score | Weekly | > [X] |
| Error Rate | Real-time | > [X%] |

### 6.2 Drift Detection

- [ ] Statistical drift monitoring (KS test, PSI)
- [ ] Model performance drift
- [ ] Data distribution monitoring
- [ ] Concept drift detection

### 6.3 Feedback Collection

| Source | Method | Frequency |
|--------|--------|-----------|
| User Feedback | [Method] | [Frequency] |
| Error Reports | [Method] | [Frequency] |
| Outcome Data | [Method] | [Frequency] |

---

## 7. Rollback Criteria

### 7.1 Automatic Rollback Triggers

| Condition | Threshold | Action |
|-----------|-----------|--------|
| Performance Drop | > [X%] | Automatic rollback |
| Error Rate Spike | > [X%] | Automatic rollback |
| Security Incident | Any | Manual review |

### 7.2 Manual Rollback Process

1. Identify triggering event
2. Assess impact on patient safety
3. Execute rollback to previous version
4. Notify users
5. Document incident
6. Root cause analysis

---

## 8. Documentation Requirements

### 8.1 Change Documentation

For each modification under the PCCP:

- [ ] Change description and rationale
- [ ] Data used (if applicable)
- [ ] Training parameters (if applicable)
- [ ] Performance evaluation results
- [ ] Comparison to baseline/previous version
- [ ] Cybersecurity validation results
- [ ] Approval signatures

### 8.2 Record Retention

| Record Type | Retention Period |
|-------------|------------------|
| Training Data | Life of device + [X years] |
| Model Versions | Life of device + [X years] |
| Test Results | Life of device + [X years] |
| Change Records | Life of device + [X years] |

---

## 9. Quality System Integration

### 9.1 Design Controls

This PCCP is integrated with the Quality Management System per 21 CFR 820:

- [ ] Design input requirements documented
- [ ] Design output specifications defined
- [ ] Design verification procedures established
- [ ] Design validation protocols approved
- [ ] Design review milestones defined

### 9.2 Change Control

All changes under this PCCP follow:

- [ ] Change request documentation
- [ ] Impact assessment
- [ ] Verification and validation
- [ ] Approval workflow
- [ ] Implementation tracking

---

## 10. Approval and Signatures

| Role | Name | Signature | Date |
|------|------|-----------|------|
| QA/RA Lead | | | |
| Development Lead | | | |
| Clinical Lead | | | |
| Cybersecurity Lead | | | |
| Executive Sponsor | | | |

---

## Appendices

### Appendix A: Performance Metrics Definitions

[Define all performance metrics used]

### Appendix B: Test Dataset Specifications

[Detailed specifications for test datasets]

### Appendix C: Acceptance Criteria Derivation

[Statistical justification for acceptance criteria]

### Appendix D: Change Log

| Version | Date | Author | Description |
|---------|------|--------|-------------|
| 1.0 | [DATE] | [AUTHOR] | Initial release |

---

*This template is provided as guidance and should be adapted to specific device requirements and regulatory jurisdiction.*
